A nanocrystal technology: to enhance solubility of poorly water soluble drugs
Keywords:
Nanotechnology, nanocrystals, techniques of production of nanocrystalsAbstract
Most of the recently developed new chemical entities are poorly water soluble and they create major problems during formulation and development of new dosage form and due to poor solubility and poor bioavailability. The drugs belong to BCS class II and class IV has problem of solubility, to overcome the solubility problem nanotechnology is most useful technique. In this review article the main focus on Nanocrystals and various techniques used for preparation of Nanocrystals. Drug nanocrystals consists pure poorly water soluble drugs without any matrix material which means that it is carrier free drug delivery. Nanocrystals technologies have been introduced as advantageous, universal formulation approaches for the BCS class II and IV drugs. Nanocrystals, with greater surface to volume ratio, can effectively increase both the dissolution rate and saturation solubility of active ingredients The Nanocrystals is suitable drug delivery system for all commonly used routes of administration such as oral, IV, SC, and IM and topical application. Nanocrystals can also be incorporated into the tablets, capsules, fast-melts and lyophilized for sterile product applications. There are no of techniques which are used for production including precipitation, milling, high pressure homogenization and combination methods such as Nano-Edge, SmartCrystal and Precipitation-lyophilization-homogenization (PLH) technology.
Downloads
References
Varaporn Buraphacheep Junyaprasert, Boontida Morakul. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs Asian journal of pharmaceutical sciences; 2015; 13-23.
Jens-Uwe A H Junghanns and Rainer H Müller Nanocrystal technology, drug delivery and clinical applications Int J Nanomedicine. 2008 Sep; 3(3): 295–310.
Moschwitzer J, Muller RH. Drug nanocrystals e the universal formulation approach for poorly soluble drugs. In: Thassu D,Deleers M, Pathak Y, editors. Nanoparticulate drug delivery systems. New York: Informa Healthcare; 2007; 71-88.
Gao L, Zhang D, Chen M. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res 2008; 10: 845-862.
Junghanns JUAH, Muller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine2008; 3(3):295e309.
Chen H, Khemtong C, Yang X, et al. Nanonization strategies for poorly water-soluble drugs. Drug Discov Today 2011; 16 (7/8):354e360.
Mishra Soumya, Saurabh Gupta, Rahul Jain, Mazumder R. Solubility Enhancement Of Poorly Water Soluble Drug By Using Nanosuspension Technology International Journal of Research and Development in Pharmacy and Life Sciences October – November; 2013; Vol. 2; No.6; 642-649.
Jasdeep Hitanga, Neha Sharma, Hitesh Chopra, Dr.Sandeep Kumar Nanoprecipitation Technique Employed For The Development Of Nanosuspension: A Review World Journal of pharmaceutical Research Volume 4 ;Issue 6;2127-2136.
J.B. Dressman, C. Reppas, In vitro–in vivo correlations for lipophilic, poorly watersolubledrugs, Eur. J. Pharm. Sci. 11 (Supplement 2) (2000) S73–S80.
Ramaiyan Dhanapal and 1 J.Vijaya Ratna Nanosuspensions Technology in Drug Delivery – A Review International Journal of Pharmacy Review and Research Vol 2; Issue; 2012; 46-52.
Abhijit A. Lonare and Sanjaykumar R. Patel Antisolvent Crystallization of Poorly Water Soluble Drugs International Journal of Chemical Engineering and Applications, Vol. 4; No. 5; October 2013; 337-340.
Prasanna Lakshmi, Giddam Ashwini Kumar Nano-suspension Technology: A Review International Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Supplement 4; 2010; 35-40.
G. Geetha, U. Poojitha, K. Arshad Ahmed Khan Various Techniques for Preparation of Nanosuspension- A Review International Journal of Pharma Research & Review, Sept 2014; 3(9):30-37.
Remon JP, VergoteGj, Vervaet C, Driessche I, Hoste S, Smedt S, Jain Ra, Demeester J, Ruddy S.An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen Int. J Pharm 2001;219;8-17.
Vishal V. Pande and Vidya N. Abhale Nanocrystal technology: A particle engineering formulation strategy for the poorly water soluble drugs Scholars Research Library 2016; 8 (5); 384-392.
Y. Wang, Y. Zheng, L. Zhang, Q. Wang, D. Zhang, Stability of nanosuspensions in drug delivery, J. Control. Release 172 (2013); 1126–1141.
A.V. Kabanov, E.V. Batrakova, V.Y. Alakhov, Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery, J. Control. Release 82; (2002); 189–212.
J. Deng, L. Huang, F. Liu, Understanding the structure and stability of paclitaxel Nanocrystals, Int. J. Pharm. 390 (2010); 242–249.
Vivek K. Pawar, Yuvraj Singh, Jaya Gopal Meher, Siddharth Gupta, Manish K. Chourasia Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery, Journal of Controlled Release 183:(2014):51–66.
Dolenc, J. Kristl, S. Baumgartner, O. Planinšek, Advantages of celecoxib Nanosuspension formulation and transformation into tablets, Int. J. Pharm. 376 (2009);204–212.
Pongpeerapat, C. Wanawongthai, Y. Tozuka, K. Moribe, K. Yamamoto, Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture, Int. J. Pharm. 352; (2008); 309–316.
D. Douroumis, A. Fahr, Stable carbamazepine colloidal systems using the cosolvent technique, Eur. J. Pharm. Sci. 30; (2007); 367–374.
R.C. Rowe, P.J. Sheskey, S.C. Owen, Handbook of Pharmaceutical Excipients,Pharmaceutical Press, London, 2006.
D. Xia, P. Quan, H. Piao, H. Piao, S. Sun, Y. Yin, F. Cui, Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability, Eur. J. Pharm. Sci. 40;(2010);325–334.
A.M. Cerdeira, M. Mazzotti, B. Gander, Formulation and drying of miconazole anditraconazole nanosuspensions, Int. J. Pharm. 443; (2013); 209–220.
J. Lee, S.-J. Lee, J.-Y. Choi, J.Y. Yoo, C.-H. Ahn, Amphiphilic amino acid copolymers asstabilizers for the preparation of nanocrystal dispersion, Eur. J. Pharm. Sci. 24(2005); 441–449.
L. Gao, D. Zhang,M. Chen, T. Zheng, S.Wang, Preparation and characterization of anoridonin nanosuspension for solubility and dissolution velocity enhancement,Drug Dev. Ind. Pharm. 33; (2007); 1332–1339.
Ghosh, S. Bose, R. Vippagunta, F. Harmon, Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibitcrystal growth, Int. J. Pharm. 409; (2011); 260–268.
L. Sievens-Figueroa, A. Bhakay, J.I. Jerez-Rozo, N. Pandya, R.J. Romañach, B.Michniak-Kohn, Z. Iqbal, E. Bilgili, R.N. Davé, Preparation and characterizationof hydroxypropyl methyl cellulose films containing stable BCS Class II drugnanoparticles for pharmaceutical applications, Int. J. Pharm. 423; (2012); 496–508.
J. Hecq, M. Deleers, D. Fanara, H. Vranckx, K. Amighi, Preparation and characterizationof nanocrystals for solubility and dissolution rate enhancement of nifedipine,Int. J. Pharm. 299; (2005); 167–177.
J.-J. Guo, P.-F. Yue, J.-l. Lv, J. Han, S.-S. Fu, S.-X. Jin, S.-Y. Jin, H.-L. Yuan, Developmentand in vivo/in vitro evaluation of novel herpetrione nanosuspension, Int. J. Pharm.441 (2013); 227–233.
Bushrab NF, Müller RH. Nanocrystals of poorly soluble drugs for oral administration. J New Drugs. 2003; 5:20–2.
Femia R. Megestrol acetate nanocrystal: Results of dose-escalating studies under fed and fasting conditions. amfAR’s 17th National HIV/AIDS Update Conference; California, USA. 2005.
Chong-Hui G, Grant DJW. Estimating the relative stability of polymorphs and hydrates from heats of solution and solubility data. J Pharmacol Sci. 2001; 909:1277–87.
A.H. Shojaei, Buccal mucosa as a route for systemic drug delivery: a review, J.Pharm. Pharm. Sci. 1 (1998); 15–30.
Hanafy A, Spahn H, Vergnaut G, Grenier p, Grozdanis MT,Lenhardt T, Pharmacokinetic evaluation of oral fenofibrate and nonosuspension and SLN in comparision with conventional suspension of micronized drug. Adv Drug Del Rev 2007;19-26.
Kipp JE. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm2004;284(1-2);109-122.
Müller RH, Böhm BHL. Nanosuspensions. In: Müller RH, Benita S, Böhm B, eds.Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs. Stuttgart: Medpharm; 1998; 149-174.
Published
How to Cite
Issue
Section
Copyright (c) 2020 R. M. Mirza, S. P. Ahirrao, S. J. Kshirsagar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
